Organon & Co. financial data

Symbol
OGN on NYSE
Industry
Pharmaceutical Preparations
Location
30 Hudson Street, Fl 33, Jersey City, New Jersey
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 162 % +2.71%
Quick Ratio 48 % +16.3%
Debt-to-equity -4.04 K %
Return On Equity -359 % -361%
Return On Assets 9.12 % +30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 257 M shares +0.83%
Common Stock, Shares, Outstanding 256 M shares +0.56%
Entity Public Float 5.3 B USD -38.4%
Common Stock, Value, Issued 3 M USD 0%
Weighted Average Number of Shares Outstanding, Basic 256 M shares +0.51%
Weighted Average Number of Shares Outstanding, Diluted 258 M shares +0.86%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.35 B USD +3.29%
Research and Development Expense 472 M USD +103%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 674 M USD -26.3%
Income Tax Expense (Benefit) -373 M USD -321%
Net Income (Loss) Attributable to Parent 1.05 B USD +40.3%
Earnings Per Share, Basic 4.09 USD/shares +39.1%
Earnings Per Share, Diluted 4.08 USD/shares +39.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 575 M USD +25.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.55 B USD +7.06%
Inventory, Net 1.26 B USD +12.7%
Other Assets, Current 811 M USD +7.42%
Assets, Current 4.2 B USD +11%
Property, Plant and Equipment, Net 1.18 B USD +11.8%
Operating Lease, Right-of-Use Asset 173 M USD -19.5%
Goodwill 4.6 B USD 0%
Assets 11.9 B USD +10.5%
Accounts Payable, Current 955 M USD -4.12%
Liabilities, Current 2.55 B USD +8.48%
Deferred Income Tax Liabilities, Net 44 M USD +46.7%
Operating Lease, Liability, Noncurrent 125 M USD -16.7%
Other Liabilities, Noncurrent 549 M USD +30.4%
Liabilities 11.8 B USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -577 M USD -8.05%
Retained Earnings (Accumulated Deficit) 573 M USD
Stockholders' Equity Attributable to Parent 48 M USD
Liabilities and Equity 11.9 B USD +10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 76 M USD -33.3%
Net Cash Provided by (Used in) Financing Activities -74 M USD +77.3%
Net Cash Provided by (Used in) Investing Activities -96 M USD -77.8%
Common Stock, Shares Authorized 500 M shares 0%
Common Stock, Shares, Issued 256 M shares +0.56%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -118 M USD +52.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 575 M USD +25.3%
Deferred Tax Assets, Valuation Allowance 309 M USD +494%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 1.17 B USD +174%
Operating Lease, Liability 171 M USD -14.1%
Depreciation 32 M USD +14.3%
Payments to Acquire Property, Plant, and Equipment 46 M USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1 B USD +35.5%
Lessee, Operating Lease, Liability, to be Paid 189 M USD -14.1%
Operating Lease, Liability, Current 46 M USD -6.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48 M USD -2.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 52 M USD -7.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) 5 M USD +66.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18 M USD -14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29 M USD -37%
Deferred Tax Assets, Operating Loss Carryforwards 35 M USD -46.2%
Deferred Federal Income Tax Expense (Benefit) -52 M USD -36.8%
Current Income Tax Expense (Benefit) 135 M USD -39.5%
Unrecognized Tax Benefits 115 M USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14 M USD -22.2%
Current State and Local Tax Expense (Benefit) 1 M USD
Current Federal Tax Expense (Benefit) 47 M USD -7.84%
Amortization of Intangible Assets 116 M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 863 M USD +130%
Share-based Payment Arrangement, Expense 105 M USD +28%
Deferred State and Local Income Tax Expense (Benefit) -5 M USD -150%
Interest Expense 526 M USD +15.1%